力寶(00226.HK)及力寶華潤(00156.HK):Maxx Coffee Singapore於新加坡獲特許營運Maxx Coffee店業務
格隆匯1月3日丨力寶(00226.HK)及力寶華潤(00156.HK)公告,於2020年1月3日,特許經營商Maxx Coffee Singapore Pte. Ltd(為力寶華潤間接非全資附屬公司,而力寶華潤則為力寶間接非全資附屬公司)與特許權授予人PT Maxx Coffee Prima訂立特許經營協議,據此,特許權授予人同意授予特許經營商於新加坡獨家權利及許可,以於期限內進行成立、發展及營運Maxx Coffee店業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.